Congenital absence of the portal vein (CAPV) is a rare malformation of the mesenteric vasculature in which visceral venous blood bypasses the liver, completely draining into the systemic circulation through a congenital porto-systemic shunt. Liver transplantation has rarely been indicated for patien
Living donor liver transplantation for hepatitis C virus cirrhosis with a huge portal vein aneurysm
β Scribed by Kensuke Miyazaki; Mitsuhisa Takatsuki; Susumu Eguchi; Masaaki Hidaka; Hirotaka Tokai; Koji Hamasaki; Yoshitsugu Tajima; Takashi Kanematsu
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 76 KB
- Volume
- 14
- Category
- Article
- ISSN
- 1527-6465
- DOI
- 10.1002/lt.21463
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The occurrence of de novo hepatocellular carcinoma (HCC) after liver transplantation (LT) for advanced HCCs has been extremely limited. In this article, a case of de novo HCC in a liver graft with sustained hepatitis C virus clearance after living donor liver transplantation (LDLT) for multiple HCCs
Congenital absence of the portal vein (CAPV) with an extrahepatic portosystemic shunt is a rare malformation; the completely absent type, Abernethy malformation type I, is especially rare. Liver transplantation for CAPV type I has been recently recognized as the only curative operation, but few repo
After liver transplantation, reinfection of the newly engrafted liver with hepatitis C virus is essentially universal in patients who are viremic at the time of transplantation. Treatment with interferon preparations with or without ribavirin is recommended in patients with marked histologic injury;